Position in REPL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,511,470
-$516,791 QoQ
Shares Held
197,578
-5.3% QoQ
Ownership
0.235%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 0%
Shared 71%
None 29%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,418,547,095 across 180 Biotechnology names. REPL ranks #123 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,212,589 | $1,434,549,489 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,837,459 | $1,419,694,318 | |
| 3 | ARGX |
Argenx SE
|
1,021,457 | $745,918,971 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,935,925 | $640,539,501 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
6,027,819 | $586,205,394 | |
| 6 | CYTK |
Cytokinetics Inc
|
8,009,489 | $527,905,416 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
6,391,816 | $479,961,458 | |
| 8 | ASND |
Ascendis Pharma A/S
|
1,757,633 | $402,023,391 |
All Filings in REPL
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,511,470 | 197,578 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,028,261 | 208,669 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $951,196 | 227,016 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $8,774,459 | 944,506 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,129,508 | 936,360 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $13,281,567 | 1,096,744 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,656,681 | 242,398 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,649,644 | 405,516 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,530,893 | 309,779 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,079,039 | 246,624 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $4,470,448 | 261,277 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,844,713 | 208,644 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,563,278 | 145,146 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $7,733,096 | 284,305 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $457,015 | 26,463 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $782,387 | 44,759 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $760,007 | 44,759 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $6,646,301 | 245,251 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $10,848,505 | 366,009 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $14,081,006 | 366,502 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||